(1)Research Laboratory on Viral Hepatitis and Health Communication, University of Yaoundé I, Yaoundé, Cameroon
(2)ECDC Fellowship Programme, Field Epidemiology path (EPIET), European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden|State Institute for Health II, Task Force for Infectious Diseases (GI), Bavarian Health and Food Safety Authority (LGL), Munich, Germany
(3)HIV/AIDS Approved Treatment Center, Yaounde General Hospital, Yaounde, Cameroon|Department of Clinical Sciences, Higher Institute of Medical Technology of Nkolodom, Yaounde, Cameroon
(4)Faculty of Medicine and Pharmaceutical Sciences, University of Dschang, Dschang, Cameroon|French National Agency for Research on AIDS and Infectious Diseases, Cameroon Site, Central Hospital of Yaoundé, Yaoundé, Cameroon
(5)PharmAccess Foundation, Amsterdam, the Netherlands
(6,10)Research Laboratory on Viral Hepatitis and Health Communication, University of Yaoundé I, Yaoundé, Cameroon
(7)Centre Pasteur of Cameroon, Yaoundé, Cameroon
(8)Joep Lange Institute, Amsterdam, the Netherlands
(9)PharmAccess Foundation, Amsterdam, the Netherlands |Joep Lange Institute, Amsterdam, the Netherlands
(11)Faculty of Medicine and Pharmaceutical Sciences, University of Dschang, Dschang, Cameroon|French National Agency for Research on AIDS and Infectious Diseases, Cameroon Site, Central Hospital of Yaoundé, Yaoundé, Cameroon|Centre for Research of Emergency and Re-emergency Diseases, Yaoundé, Cameroon